Phase I dose-escalation and -expansion study of telisotuzumab (ABT-700), an Anti-c-met antibody, in patients with advanced solid tumors
Journal
Molecular Cancer Therapeutics
Journal Volume
19
Journal Issue
5
Pages
1210-1217
Date Issued
2020
Author(s)
Strickler J.H.
LoRusso P.
Salgia R.
Kang Y.-K.
Yen C.J.
Ansell P.
Motwani M.
Wong S.
Yue H.
Wang L.
Reilly E.
Afar D.
Naumovski L.
Ramanathan R.K.
SDGs
Publisher
American Association for Cancer Research Inc.
Type
journal article